跳转至内容
Merck
CN
  • Resistance to tetracycline, macrolide-lincosamide-streptogramin, trimethoprim, and sulfonamide drug classes.

Resistance to tetracycline, macrolide-lincosamide-streptogramin, trimethoprim, and sulfonamide drug classes.

Molecular biotechnology (2002-04-09)
Marilyn C Roberts
摘要

The discovery and use of antimicrobial agents in the last 50 yr has been one of medicine's greatest achievements. These agents have reduced morbidity and mortality of humans and animals and have directly contributed to human's increased life span. However, bacteria are becoming increasingly resistant to these agents by mutations, which alter existing bacterial proteins, and/or acquisition of new genes, which provide new proteins. The latter are often associated with mobile elements that can be exchanged quickly across bacterial populations and may carry multiple antibiotic genes for resistance. In some case, virulence factors are also found on these same mobile elements. There is mounting evidence that antimicrobial use in agriculture, both plant and animal, and for environmental purposes does influence the antimicrobial resistant development in bacteria important in humans and in reverse. In this article, we will examine the genes which confer resistance to tetracycline, macrolide-lincosamide-streptogramin (MLS), trimethoprim, and sulfonamide.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
甲氧苄啶, ≥98.5%
Sigma-Aldrich
甲氧苄啶, ≥99.0% (HPLC)
Supelco
甲氧苄啶, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
甲氧苄啶, VETRANAL®, analytical standard
USP
甲氧苄啶, United States Pharmacopeia (USP) Reference Standard
甲氧苄啶, European Pharmacopoeia (EP) Reference Standard